AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENTExclusive Licensing and Distribution Agreement • June 6th, 2007 • ProLink Holdings Corp. • Services-prepackaged software • Arizona
THIS AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into on May 8, 2006 (the “Effective Date”), by and between ProLink Solutions, LLC, a Delaware limited liability company (“Supplier”), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (“Distributor”).
EX-10.1 2 dex101.htm AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTIBUTION AGREEMENT AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENTExclusive Licensing and Distribution Agreement • May 5th, 2020 • Arizona
THIS AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into on May 8, 2006 (the “Effective Date”), by and between ProLink Solutions, LLC, a Delaware limited liability company (“Supplier”), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (“Distributor”).
EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENTExclusive Licensing and Distribution Agreement • June 9th, 2016 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
This Exclusive Licensing and Distribution Agreement (“Agreement”) is entered into and effective as of June 03, 2016 (“Effective Date”), by and between FluoroPharma Medical, Inc., a company organized and existing under the laws of Nevada, with its principal place of business located at 8 Hillside Avenue, Suite 207, Montclair, New Jersey, U.S., (“FluoroPharma”) and Sinotau USA, Inc. (a subsidiary of Sinotau Pharmaceutical Group, Chinese Name: 北京先通国际医药科技股份有限公司, i.e. Beijing Xiantong Guoji Yiyao Keji Gufen Youxian Gongsi a company organized and existing under the laws of the People’s Republic of China with registered address at Room 6168, #1 Building, #2 Courtyard, Heng Fu Middle Street, Science City, Fengtai District, Beijing China) a company organized under the laws of Delaware, with its principal place of business located at 27 Drydock Avenue, STE 7, Boston, Massachusetts, U.S. (“Sinotau”). FluoroPharma and Sinotau are each referred to herein by name or as a “Party” or, collectively, as
EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENTExclusive Licensing and Distribution Agreement • August 14th, 2008 • ProLink Holdings Corp. • Services-prepackaged software • Arizona
THIS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into on May 12, 2008 (the “Effective Date”), by and between ProLink Solutions, LLC, a Delaware limited liability company (“Supplier”), and SPORT BUSINESS GROUP, a company formed and existing under the laws of France (“Distributor”).
EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENTExclusive Licensing and Distribution Agreement • December 23rd, 2005 • Amalgamated Technologies Inc • Retail-eating places • Arizona
THIS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into on October 29, 2004, by and between ProLink/ParView, LLC, a Delaware limited liability company (“Supplier”), and Elumina Iberica SA; a company formed and registered the country of Spain (“Distributor”).
Altamira Therapeutics and Nuance Pharma Enter into Exclusive Licensing and Distribution Agreement for Bentrio™ in China and Additional Asian MarketsExclusive Licensing and Distribution Agreement • March 4th, 2022 • Altamira Therapeutics Ltd. • Pharmaceutical preparations
Hamilton, Bermuda, March 4, 2022 – Altamira Therapeutics Ltd. (NASDAQ: CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, announced today that it has entered into an exclusive licensing and distribution agreement (the “Agreement”) for Bentrio™, its nasal spray for protection against airborne viruses and allergens, with Nuance Pharma Ltd. (“Nuance”) in Chinese Mainland, Hong Kong, Macau and South Korea (the “Territory”).
